In alignment with prior findings of NLGN3 shedding from glioma cells2, we readily detected both NLGN3 and CSPG4 protein in CSF from two of four glioma patients, and none of the leukemia patients (Fig. 1e). Here, CSPG4 is linked to central nervous system cancer.